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Abstract
Background: In areas where both tuberculosis (TB) and nontuberculous mycobacteria (NTM) are prevalent,
descriptive studies of the clinical features of individual mycobacteria are needed to inform clinical triage.
Methods: We queried the University of Virginia Clinical Data Repository for all mycobacterial infections from 2001-
2009.
Results: Of 494 mycobacterial infections in 467 patients there were 22 species. Patients with pulmonary Tb were
more likely to be reported as immigrants (p < 0.001) and less likely to have a predisposing risk factor for NTM (pre-
existing lung disease or host predisposition; p = 0.002). Review of chest CT scans revealed that TB infection was
more likely to exhibit cavities and pleural effusion than NTM infection (p < 0.05). Among NTM infections M.
kansasii, M. xenopi, and M. fortuitum were more likely than MAC to have cavities. There were at least 83 patients
that met criteria for NTM lung disease and these were caused by 9 species. M. abscessus infection was associated
with cystic fibrosis and M. xenopi infection was associated with male gender.
Conclusions: In our center mycobacterial infections were common and of diverse species. Immigrant status,
cavities, and effusion were associated with TB vs. NTM.
Background
A better understanding of the epidemiology of mycobac-
terial infections leads the research agenda issued by
national NTM guidelines [1]. NTM infections are
usually not reported to public health departments, thus
data on incidence and species distribution are sparse.
However there have been suggestions that NTM disease
is increasing in some areas [2,3], making the demogra-
phy and species distribution of these infections impor-
tant to understand. The mid-Atlantic and southeastern
United States are known to be high incidence regions
for mycobacteria, likely related to a high prevalence of
NTM in local soils [4]. The University of Virginia hospi-
tal is a tertiary referral center that receives patients from
across the region. Thirty years have passed since the last
systematic report of mycobacterial infections at our
institution [5]. Thus we sought to describe the epide-
miology, clinical characteristics, and radiology of all
mycobacterial infections seen at our hospital from 2001-
2009. To our knowledge, this is among the largest radio-
graphic series of pulmonary mycobacterial infections
reported, with 244 chest CT scans available for analysis.
The clinical approach to mycobacterial infection is
vexing until speciation is confirmed, a process that can
take weeks. In particular, when faced with positive acid-
fast bacilli smears or positive growth, the dilemma
emerges of whether to treat empirically for TB or an
NTM or wait. Rapid nucleic acid amplification tests for
Tb can be useful in this scenario but are only approved
for sputum or bronchoalveolar lavage material and are
not always available. The decision to defer treatment for
TB risks ongoing infectiousness and clinical deteriora-
tion, while presumptive treatment for TB incurs signifi-
cant polypharmacy and may trigger contact
investigations. We therefore sought to identify clinical
parameters that could aid in predicting TB infection
over other NTM in our setting.
Methods
Clinical data collection
The University of Virginia Health System is a 577-bed
hospital with approximately 28,000 inpatient admissions
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University of Virginia Clinical Data Repository for
laboratory results that included the terms “mycobac-
teria” or “acid fast bacilli” from January 01, 2001
through August 31, 2009. Clinical information sought
for each patient included sex, age, other medical condi-
tions, and site of infection. Site of infection was categor-
ized into five possibilities, including lung (including
sputum, bronchoalveolar lavage, and pleural fluids);
skin, soft tissue, and bone; multiple/disseminated, if two
or more specimens came from two or more sites (per-
ipheral blood, stool, sputum, BAL, catheters, synovial
fluid); lymphatic; and other sites, which included geni-
tourinary, pericardium, catheters and surgical wounds.
Repeat positive cultures with the same species in the
same patient from the same site were considered one
infection during this study period. Chest CT scans
obtained within six weeks of mycobacterial specimen
collection from sputum, bronchoalveolar lavage (BAL)
or lung tissue were analyzed. CT scan reports were read
for description of bronchiectasis, nodules, cavities, or
pleural effusion. Scans without any such findings were
reported as having none. The study was approved by
the University of Virginia Institutional Review Board.
Definitions
American Thoracic Society (ATS)/Infectious Disease
Society of America (IDSA) guidelines were applied to
patients with pulmonary mycobacteria (1). We adhered
to the ATS/IDSA definition of two or more sputa or
one bronchoalveolar lavage specimen that was culture
positive for NTM, plus chest CT findings of bronchiec-
tasis, nodules, or cavitary lesions, plus no other alterna-
tive explanation for disease after chart review.
Species identification
Clinical specimens were prepared by standard protocol
and inoculated for culture on Lowenstein-Jensen slants
and in liquid media throughout the study period. Identi-
fication of mycobacterial species was made by gene
probes (AccuProbe, Gen-Probe, San Diego, CA) for M.
avium complex (MAC), M. gordonae and M. tuberculo-
sis complex. Speciation not determined by these meth-
odologies was resolved by sequencing of the 16S rDNA
or ITS gene. NTM drug susceptibilities were obtained as
referral tests.
Statistics
Species distribution by site of infection was described
with simple frequencies and proportions. Annual trends
in mycobacterial infection were examined by Pearson
correlation. Means and medians were compared using t-
test and Mann-Whitney U test, respectively. Categorical
variables were analyzed with chi-square or Fisher’s exact
test. Proportion of a species for a site was analyzed
against other species by comparing the proportion’s 95%
confidence intervals, which had to be non-overlapping
and p < 0.05 by Fisher’s exact test to meet statistical sig-
nificance. Bivariate logistic regression was used to deter-
mine risk factors for TB among all subjects with
pulmonary specimens and separately among those with
CT scans. All p values were two-tailed. Data were ana-
lyzed with SPSS Statistics 17.0 software.
Results
Mycobacterial isolates and species distribution
Query of the University of Virginia Clinical Data Reposi-
tory yielded 2,823 “hits” for mycobacteria or acid-fast
bacilli. These results were then cleaned manually and
found to represent 494 unique mycobacterial infections
from 467 different patients (due to several mixed infec-
tions) involving at least 22 species (Table 1). Ninety-
eight percent of patients had complete clinical informa-
tion. Numbers of clinically significant infections were
examined over time for each calendar year (Figure 1).
M. avium complex (MAC) was the most prevalent spe-
cies each year.
Frequency and site of mycobacterial infection
We then examined the different anatomic sources of
mycobacterial infection. For this analysis we included
M. gordonae because these infections can confound clin-
ical decision-making and must be considered until spe-
ciation is known. Lung was the major site of infection
(n = 394, 80% of total), followed by skin, soft tissue, or
bone (n = 35, 7%), and multiple sites/disseminated
infection (n = 30, 6% of total). M. marinum infections
exclusively derived from skin, soft tissue, or bone and
M. gordonae was associated with lung, p < 0.05. The
majority (75%) of lung mycobacteria were either MAC
or M. gordonae. Additionally, fully 7% of lung mycobac-
teria were “other” NTM, constituted by 15 species
including 5 M. xenopi and 5 M. terrae infections. Of
note, 9 of the 22 patients with Tb from a lung source
had both bronchoalveolar lavage and sputum obtained,
and in 5 of 9 instances both were positive, in 4 of 9
instances only sputum was positive, and in no instance
was only bronchoalveolar lavage positive.
Risk factors for pulmonary Tb
Given the frequency of pulmonary mycobacterial infection,
we sought to identify clinical factors that could distinguish
TB from NTM. Again, since the clinician is presented
with a positive pulmonary AFB smear or culture while
speciation is pending, it is logical to include M. gordonae
at this point. Features of individuals with pulmonary Tb
versus NTM are shown in Table 2. Patients with pulmon-
ary Tb were more likely to be reported as immigrants (p <
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= 0.002). Specific risk factors we included were pre-exist-
ing lung disease (defined as any of asthma, alpha-1-anti-
trypsin, emphysema/COPD, cystic fibrosis, interstitial lung
disease, pulmonary alveolar proteinosis, pulmonary fibro-
sis, sarcoidosis, silicosis), diabetes, HIV, end-stage renal
disease, collagen vascular disease, and history of transplant
or cancer.
Chest CT findings in pulmonary mycobacterial infections
Among the 363 patients with pulmonary mycobacterial
infection 244 had chest CT scans performed within 6
weeks of the specimen. The radiologists’ findings were
read for description of bronchiectasis, cavities, and
nodules, since these are the key radiographic metrics of
NTM lung disease. The frequency of pleural effusions
was also examined. Patients with TB were more likely to
have cavities (p = 0.01) and effusions (p = 0.005) than
patients with NTM (Figure 2 and Table 2). Within
NTM, M. fortuitum, M. kansasii,a n dM. xenopi were
more likely to exhibit a cavitary pattern than MAC
infection (3/8, 3/9, and 4/5 vs. 9/97, respectively, p <
0.05). Otherwise there was no statistically discernable
pattern for a given species and it was common for chest
CT scans to reveal nodules and/or bronchiectasis.
Respective CT findings are shown for M. tuberculosis,
M. kansasii, M. xenopi, and M. avium (Figure 3).
NTM lung disease
We then sought to discern if there were predictors for
NTM lung diseases of particular species. We limited
this examination to those patients where we could
demonstrate all ATS/IDSA criteria for NTM lung dis-
ease had been fulfilled (n = 83, Table 3). M. gordonae
infections were excluded as likely environmental con-
taminants. NTM lung disease patients with MAC were
of a higher median age than those with M. abscessus or
M. kansasii (p < 0.05), owing largely to a high rate of
elderly women with MAC (average age 63 vs. 52 years
for males, p = 0.05). Cystic fibrosis was statistically asso-
ciated with both M. abscessus lung disease and mixed
NTM infections (CF occurred in 3 of 8 M. abscessus
infections vs. 3 of 72 non-M. abscessus infections, and
likewise occurred in 3 of 8 mixed infections vs. 3 of 72
non-mixed infections, and, p < 0.05). M. fortuitum lung
disease was uncommon (3/83) but 66% were associated
with cancer. No other host characteristics were statisti-
cally associated with particular mycobacterial species.
Antibiotic susceptibility results
Susceptibilities were performed on 24 (12%) MAC iso-
lates and 23 (96%) were susceptible to clarithromycin
Table 1 Site of infection for mycobacterial isolates, 2001-2009 (n = 494)
Species (n; %) Lung (n) Skin, soft tissue, bone (n) Multiple/
Disseminated (n)
Lymphatic (n) Other site
a (n)
TB (37) 22 2 5 3 5
MAC (202) 157 11 18 11 5
M. gordonae (142) 137 0 0 0 5
b
M. abscessus (22) 16 3 1 1 1
M. fortuitum (19) 12 5 1 0 1
M. chelonae (14) 7 3 3 0 1
M. kansasii (14) 14 0 0 0 0
M. marinum (8) 0 8 0 0 0
Other NTM (36)
c 29 3 2 0 2
Total (494) 394 35 30 15 20
aOther sites included genitourinary, pericardium, catheters, and wounds,
bM. gordonae from other sites included 2 from urine and 2 from stool.
c Other NTM from lung included 1 M. arupense,1M. interjectum,2M. kubicae,1M. margeritense,1M. mucogenicum,2M. nebraskense,1M. paraffinicum,3M.
peregrinum,2M. scrofulaceum,2M. simiae,1M. szulgai,5M. terrae,1M. triplex, 1 unidentifiable NTM, 5 M. xenopi. Other NTM from skin, soft tissue, and bone
contained 1 M. smegmatis,1M. peregrinum, and 1 M. xenopi infection. Other NTM from multiple/disseminated sites included 1 M. immunogenum and 1 M.
haemophilum. Other NTM from Other sites included 1 M. fluoranthenivorans catheter infection and 1 M. terrae culture from urine.
Figure 1 Mycobacterial infections over time at UVA Hospital.
All mycobacterial infections at University of Virginia Hospital from
2001-2008 were analyzed by year. p = 0.11 for increase over time.
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abscessus isolates and were reported as susceptible to
clarithromycin in 9 (90%), to amikacin in 9 (90%), and
to cefoxitin in 3 (30%).
Discussion
This current study of mycobacterial infections is drawn
from a geographic area prevalent for both NTM and TB
and spans nearly a decade. The study describes impor-
tant epidemiology regarding demography, speciation,
and pathogenesis, with particular attention paid to pul-
monary mycobacterial infections and chest CT scan
findings. Given the lack of mandatory reporting of
NTM, studies from large referral institutions such as
this are critical to understand regional patterns or emer-
ging trends. We observed a non-statistically significant
rise in the number of mycobacterial isolates over the
last decade, significant species diversity, with more total
cases of pulmonary NTM than during an equivalent
time period from our institution thirty years ago [5].
Estimation of the true change in incidence is difficult
from these data given alterations in population referral,
potentially heightened clinician suspicion of NTM, and
improved diagnostics, however our findings complement
trends in other parts of the world that suggest increas-
ing rates of NTM disease and species diversity [2,3,7].
Among patients meeting criteria for NTM lung dis-
ease, MAC remained the overwhelming pathogenic spe-
cies, consistent with previous findings at our institution
Table 2 Features of patients with pulmonary M. tuberculosis and nontuberculous mycobacteria infection.
Characteristic Total
n = 363 (%)
NTM
n = 342 (%)
TB
n = 21 (%)
P value
Age (mean yrs) [SE mean]
Age≥60 yrs
57.2 [1.0]
186 (51)
57.6 [0.9]
176 (51)
50.0 [5.5]
10 (48)
p = 0.19
p = 0.73
Gender: Male 181 (49) 171 (50) 10 (48) p = 0.83
Immigrant 17 (5) 3 (1) 14 (67) p < 0.001
Predisposing risk factor for NTM** 261 (72) 252 (75) 9 (43) p = 0.002
CT scan
Cavities 36 (14) 31 (13) 5 (38) p = 0.01
Bronchiectasis 58 (24) 56 (24) 2 (15) p = 0.74
Nodules 111 (45) 103 (45) 8 (61) p = 0.23
Effusion 15 (6) 11 (5) 8 (61) p = 0.005
*Note total number of pulmonary patients (n = 363) is lower than total number of lung infections (n = 394) because of mixed infections.
**Predisposing risk factors for NTM = pre-existing lung disease (COPD, Cystic fibrosis, asthma, alpha-1-antitrypsin, interstitial lung disease, pulmonary alveolar
proteinosis, pulmonary fibrosis, sarcoidosis, and silicosis) or host predisposition (diabetes, end-stage renal disease, collagen vascular disease, cancer, HIV,
transplantation).


Figure 2 Chest CT scan findings in patients with pulmonary
mycobacterial infection (n = 244). CT scans were performed
within 6 weeks of pulmonary specimen and radiologist reports read
for findings of bronchiectasis, nodules, cavities and/or effusion. (A)
All 244 CT scans could be binned into categories of either
bronchiectasis, bronchiectasis + nodules (B+N), nodules, cavities +
nodules (C+N), cavities, bronchiectasis + cavities (B+C), effusion,
nodules + effusion (N+E). *, p < 0.05 for M. tuberculosis rate of
cavities or effusion vs. all NTM.
 
 
Figure 3 Representative CT images for mycobacterial
infections. Shown are images for (A) M. tuberculosis, with cavities
(arrows), in a 35 y.o. foreign-born individual with no predisposing
risk factor for NTM, (B) M. kansasii, with cavity (arrow), in a 51 y.o.
male with COPD, (C) M. avium, with nodule (arrow), in a 70 y.o.
female with COPD, and (D) M. xenopi, with 7 cm peripheral wedge
shaped consolidation (arrow) with air cavities, in 66 y.o. male with
COPD.
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After MAC we observed significant diversity of 8 other
species, as well as 8 mixed infections, which suggests
that clinicians should not readily discount a particular
species in this region. We looked for risk factors for
particular NTM lung species, including age, gender,
chronic obstructive pulmonary disease, cystic fibrosis,
other lung diseases, diabetes, end stage renal disease,
collagen vascular disease, cancer, HIV and transplanta-
tion. The only obvious host characteristic that was
linked with a particular NTM lung disease was male
gender with M. xenopi and cystic fibrosis with M.
abscessus. The latter association has been appreciated
before [9] but not usually to this extent, where fully 38%
of our M. abscessus infections were associated with CF.
This may be a feature of our center which is a tertiary
referral center for lung transplantation. Of course we
m a yh a v em i s s e di d e n t i f y i n gr i s kf a c t o r sd u et ol o w
power for most species besides MAC, but it still sug-
gests to us that in our region mycobacteria do not pre-
sent stereotypically, thus pathogenesis is likely not
species-specific, and no particular species can be easily
considered low virulence (as M. fortuitum is sometimes
considered [1]). Another finding was the relatively low
proportion of individuals that strictly met ATS/IDSA
criteria for NTM lung disease: 82 of 342 pulmonary
NTM infections or 24%. This contrasts with other stu-
dies where more than half of all pulmonary NTM
patients met these criteria [10]. Our suspicion is that
this does not reflect true differences but that our pro-
portion of patients that met criteria for NTM lung
disease was an underestimate because we relied tightly
on chest CT scans performed at our institution within 6
weeks of the isolate.
Over two thirds of patients with a pulmonary myco-
bacterial isolate had a CT scan available for analysis,
making this one of the largest radiographic series of
NTM lung infections available. NTM lung disease has
historically been ascribed two radiographic categories:
fibrocavitary disease similar to Tb, especially in males,
or nodular bronchiectatic disease, especially in females.
We could not discern such a distinction and found sig-
nificant overlap across the species in terms of cavities,
nodules, and bronchiectasis regardless of gender. Pre-
vious reports have also failed to find a difference in radi-
ologic appearance of NTM infection based on the
mycobacterial species [11-13]. However a few trends
were revealed. Notably, M. fortuitum and M. kansasii
had similar patterns, with a larger proportion with cav-
ities than the most common NTM species, MAC. Cavi-
tation has been thought to be rare with M. fortuitum
and the other rapidly growing mycobacteria [14].
Among the patients with M. fortuitum and cavities, all
had an immunosuppressive condition or pre-existing
lung disease that may have contributed. The high fre-
quency of cavities is well known for M. kansasii [15,16],
often times with thinner walled cavities that Tb, how-
ever this latter feature was not reliably described in our
radiology reports. Cavities have been reported in up to
50% CT scans in patients with active MAC infection
[17], yet others report more bronchiectasis and nodules
[13,18,19]. Our series found the latter, with nearly two-
Table 3 Host characteristics among patients meeting ATS/IDSA criteria for NTM lung disease
Demographics Lung disease Host predisposition
Organism (N) Age
(median)
Sex
M:F
Immigrant n
(%)
COPD
n (%)
Cystic
Fibrosis
n (%)
Other lung
dz
a
n (%)
DM/ESRD/
CVD
n (%)
Cancer
n (%)
HIV
n
(%)
Transplant
n (%)
Total meeting ATS/IDSA
criteria (83)
59 28:55 1 (1) 19
(23)
6 (7) 13 (16) 11 (13) 10 (12) 3 (4) 5 (6)
MAC (57) 62 15:42 0 10
(18)
3 (5) 8 (14) 8 (14) 8 (14) 2 (4) 2 (4)
M. kansasii (4) 43 3:1 0 2 (50) 0 1 (25) 0 0 0 0
M. xenopi (4) 70 4:0
b 0 2 (50) 0 0 0 0 1
(25)
0
M. abscessus (3) 43 0:3 1 (33) 1 (33) 0 1 (33) 0 0 0 1 (33)
M. fortuitum (3) 62 0:3 0 0 0 1 (33) 1 (33) 2 (66) 0 0
Mixed
c (8) 42 4:4 0 2 (50) 3 (38
d) 1 (13) 2 (25) 0 0 2 (25)
Other
e (4) 59 2:2 0 2 (50) 0 1 (25) 3 (75) 0 0 0
aOther lung disease = asthma, alpha-1-antitrypsin, interstitial lung disease, pulmonary alveolar proteinosis, pulmonary fibrosis, sarcoidosis, and silicosis.
bM. xenopi associated with male gender, p = 0.01.
cMixed included 4 MAC + M. abscessus infections, 1 MAC + M. fortuitum infection, 1 MAC + M. terrae infection, and 1 M. abscessus + M. chelonae infection. 5 of 8
M. abscessus infections were mixed, vs. 3 of 75 non-abscessus infections, p < 0.05.
d Cystic fibrosis was statistically associated with mixed infections vs. non-mixed infections, p < 0.05.
e Other infections included 1 each of M. chelonae, M. simiae, M. szulgai, and M. terrae.
DM = diabetes mellitus. ESRD = end-stage renal disease. CVD = collagen vascular disease.
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and CT scans exhibiting nodules alone or nodules with
bronchiectasis. The strength of our series is that it was
larger than any of these previous studies.
We acknowledge that our radiologic analysis has lim-
itations. Radiologists may have received information on
the microbiologic diagnosis from the clinicians, and this
lack of blinding may have led to bias in reporting find-
ings historically associated with the known diagnosis or
present on prior scans that we did not review. Further-
more, it may be that patients with characteristic findings
on chest radiograph were not sent for chest CT, as may
be evidenced by the 21 patients with TB from pulmon-
ary specimens, of whom only 13 had a chest CT avail-
able for analysis. On the other hand these limitations
are the norm in clinical practice.
The first scenario clinicians face is a positive acid-fast
smear or mycobacterial culture and determining a man-
agement course while awaiting results of speciation. In
comparing risk factors for TB or NTM among patients
with pulmonary mycobacterial specimens, likelihood
ratio analysis of immigrant status led to post-test prob-
abilities of TB exceeding 80%. The magnitude of this
observation may be secondary to reporting bias since a
clinician may have been more likely to document in the
chart a patient as an “immigrant” if TB was confirmed.
Furthermore, the term “immigrant” was not defined or
validated. Therefore although our rates of immigrants
among Tb and NTM patients may be imperfect they are
likely reasonable. Indeed, our proportion of Tb seen
among immigrants, 67%, is almost identical to our
state’s rate of Tb among foreign-born individuals. On
the topic of specimen type, our data would emphasize
the importance of sputum over bronchoscopy to evalu-
ate for pulmonary Tb, since sputum was as or more
sensitive than bronchoalveolar lavage fluid for Tb
growth in all 9 instances where both were sent.
Finally, our series revealed a large number of “other”
NTM, including at least 3 infections of M. peregrinum,
M. terrae,a n dM. xenopi as well as more than a dozen
others. This adds important detail to the known epide-
miology of NTM. For instance, M. simiae has been
appreciated mostly from the southwestern United States
[1], but not our region. Additionally, the NTM guide-
lines describe M. terrae as “potentially pathogenic,”
which we would strongly support. And M. xenopi is
reported as rare in the US, although we observed 5
infections with some extensive disease.
Conclusions
In summary, we found a substantial number and diver-
sity of mycobacteria isolated from patients at our center
throughout the past decade. Series such as this from
other centers are welcomed to better inform the
complex and emerging epidemiology of mycobacterial
infections.
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